54 349 54 349 Pill - white & yellow capsule/oblong, 16mm
Pill with imprint 54 349 54 349 is White & Yellow, Capsule/Oblong and has been identified as Temozolomide 20 mg. It is supplied by Roxane Laboratories, Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 349 54 349
Temozolomide
- Imprint
- 54 349 54 349
- Strength
- 20 mg
- Color
- White & Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roxane Laboratories, Inc.
- National Drug Code (NDC)
- 00054-0321 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A potato,
tartaric acid,
magnesium stearate,
gelatin,
titanium dioxide,
FD&C Yellow No. 5,
FD&C Yellow No. 6,
ferrosoferric oxide,
ferric oxide red,
alcohol,
ferric oxide yellow,
polyethylene glycol,
shellac,
isobutyl alcohol
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
